In particular, age-dependent decline in motor function and loss of nigrostriatal dopaminergic neurons have been observed in mouse models of PSAP, suggesting that PSAP may be useful as an animal model of PD [20, 21]. This evidence concerns the gene PSAP and Parkinson disease.